Attached files

file filename
10-K - 10-K - Ultragenyx Pharmaceutical Inc.rare-10k_20191231.htm
EX-32.1 - EX-32.1 - Ultragenyx Pharmaceutical Inc.rare-ex321_10.htm
EX-31.2 - EX-31.2 - Ultragenyx Pharmaceutical Inc.rare-ex312_7.htm
EX-31.1 - EX-31.1 - Ultragenyx Pharmaceutical Inc.rare-ex311_6.htm
EX-23.1 - EX-23.1 - Ultragenyx Pharmaceutical Inc.rare-ex231_8.htm
EX-10.71 - EX-10.71 - Ultragenyx Pharmaceutical Inc.rare-ex1071_644.htm
EX-10.70 - EX-10.70 - Ultragenyx Pharmaceutical Inc.rare-ex1070_645.htm
EX-10.25 - EX-10.25 - Ultragenyx Pharmaceutical Inc.rare-ex1025_647.htm
EX-10.10 - EX-10.10 - Ultragenyx Pharmaceutical Inc.rare-ex1010_646.htm
EX-4.3 - EX-4.3 - Ultragenyx Pharmaceutical Inc.rare-ex43_731.htm

Exhibit 21.1

Significant Subsidiaries of Ultragenyx Pharmaceutical Inc.

Name of Subsidiary

 

Jurisdiction of Incorporation

Ultragenyx Holdco LLC

 

Delaware

Ultragenyx UK Ltd

 

United Kingdom

Ultragenyx Europe GmbH

 

Switzerland

Ultragenyx Germany GmbH

 

Germany

Ultragenyx Brasil Farmacêutica Ltda

 

Brazil

Ultragenyx Argentina SRL

 

Argentina

Ultragenyx Netherlands B.V.

 

Netherlands

Ultragenyx France SAS

 

France

Ultragenyx Colombia SAS

 

Colombia

Ultragenyx Canada Inc.

 

Canada

Ultragenyx México, S. de R.L. de C.V.

 

Mexico